Bayer Animal Health was a major division of Bayer AG, dedicated to researching, developing, and marketing innovative treatments and solutions for the health and well-being of companion animals and livestock globally. With a rich history in veterinary medicine, it offered a wide range of products including parasiticides (like the well-known Advantage® and Seresto® brands), pharmaceuticals, and farm animal health solutions. In August 2020, Bayer Animal Health was acquired by Elanco Animal Health, combining two leading players in the animal health industry. This information page reflects Bayer Animal Health prior to its acquisition.
Served as the global headquarters for the Animal Health division, overseeing strategic direction, R&D leadership, global marketing, and administrative functions for veterinary products.
Located within Bayer's expansive Monheim campus, featuring modern research laboratories, office complexes, and integrated infrastructure shared with other Bayer divisions. The campus is known for its focus on scientific research and development.
Reflected Bayer's corporate culture of innovation, scientific rigor, and global collaboration, with a specific focus within the division on dedication to animal welfare, veterinary science, and developing solutions for animal health challenges.
As the nerve center of Bayer's global animal health operations, it drove the development and commercialization of key products, shaped market strategies, and coordinated activities across numerous countries.
Prior to its acquisition, Bayer Animal Health operated globally, with research and development, manufacturing, and sales & marketing functions supporting veterinarians, farmers, and pet owners in over 100 countries. Key areas included pharmaceuticals, vaccines, parasiticides (such as Advantage® and Seresto®), and farm animal well-being solutions.
Alfred-Nobel-Str. 50
Monheim am Rhein
North Rhine-Westphalia
Germany
Address: 12707 Shawnee Mission Pkwy, Shawnee, KS 66216, USA (Historical Address)
Key center for Bayer Animal Health's business in the United States and the broader North American market, driving product innovation, regulatory affairs, and customer support for the region.
Address: Projensdorfer Str. 324, 24106 Kiel, Germany (Associated with KVP Pharma + Veterinär Produkte GmbH, a Bayer entity)
Supported the European and global markets by developing and supplying specialized veterinary medicines, acting as a center of excellence for certain product categories.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Bayer Animal Health' leadership includes:
Bayer Animal Health has been backed by several prominent investors over the years, including:
Prior to its acquisition by Elanco in August 2020, significant executive changes solely within Bayer Animal Health were minimal. The primary 'executive event' was the transition of the entire division and its leadership framework due to the sale to Elanco. This section reflects the context of that period.
Discover the tools Bayer Animal Health uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
As a division of Bayer AG, Bayer Animal Health employees typically used Bayer's standard corporate email format. The following is an example of Bayer's common email structure.
firstname.lastname@bayer.com
Format
jane.doe@bayer.com
Example
70%
Success rate
Elanco Animal Health • August 1, 2020
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has completed the acquisition of Bayer Animal Health. The transaction, valued at $6.89 billion at closing, enhances Elanco's portfolio and capabilities, positioning it as a long-term leader in the attractive animal health industry by combining Elanco's longstanding focus on the veterinarian with Bayer Animal Health’s direct-to-consumer expertise....more
Bayer Newsroom • August 20, 2019
Bayer has agreed to sell its Animal Health business unit to Elanco Animal Health Incorporated for 7.6 billion U.S. dollars. The transaction will create a leading global animal health company, with Elanco acquiring Bayer's portfolio of trusted brands and strengthening its innovation capabilities. The sale marked a significant strategic move for Bayer to focus on its core life science businesses....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Bayer Animal Health, are just a search away.